Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.47ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.47ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
BA.5.2.47NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
ED.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
ED.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
ED.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.86China
ED.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
BN.1.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CQ.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CQ.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CQ.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
CQ.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3181.36China
CH.1.1.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.19ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.19ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.19ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.19NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.38.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.38.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.38.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.38.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.19.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.19.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.19.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.19.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.43ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.43ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.43ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.43NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.2.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.2.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.2.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
BF.7.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.214ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.214ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.214ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used